Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity

Publicaciones

RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer

Autores: Marina Ciscar, Eva M Trinidad, Gema Perez-Chacon, Maria Jimenez, Maria J Jimenez-Santos, Hector Perez-Montoyo, Adrian Sanz-Moreno, Andrea Vethencourt, Michael Toss, Anna Petit, Maria T Soler-Monso, Victor Lopez, Jorge Gomez-Miragaya, Clara Gomez-Aleza, Lacey E Dobrolecki, Michael T Lewis, Alejandra Bruna, Silvana Mouron, Miguel Quintela-Fandino, Fatima Al-Shahrour, Antonio Martinez-Aranda, Angels
Publicado en: EMBO Molecular Medicine, 2023, ISSN 1757-4684
Editor: EMBO Press
DOI: 10.15252/emmm.202216715

Rank ectopic expression in the presence of Neu and PyMT oncogenes alters mammary epithelial cell populations and their tumorigenic potential

Autores: Alex Cordero, Patricia G. Santamaría, Eva Gonzalez-Suarez
Publicado en: JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2023, ISSN 1083-3021
Editor: Kluwer Academic/Plenum Publishers
DOI: 10.1007/s10911-023-09530-4

RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

Autores: Sandra Benítez, Alex Cordero, Patricia G. Santamaría, Jaime Redondo-Pedraza, Ana S. Rocha, Alejandro Collado-Solé, Maria Jimenez, Adrian Sanz-Moreno, Guillermo Yoldi, Juliana C. Santos, Ilaria De Benedictis, Clara Gómez-Aleza, Sabela Da Silva-Álvarez, Kevin Troulé, Gonzalo Gómez-López, Noelia Alcazar, Ignacio Palmero, Manuel Collado, Manuel Serrano, Eva Gonzalez-Suarez,
Publicado en: Developmental Cell, 2021, Página(s) 1727-1741.e7, ISSN 1534-5807
Editor: Cell Press
DOI: 10.1016/j.devcel.2021.04.022.

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation

Autores: Guillermo Yoldi, Pasquale Pellegrini, Eva M. Trinidad, Alex Cordero, Jorge Gomez-Miragaya, Jordi Serra-Musach, William C. Dougall, Purificación Muñoz, Miguel-Angel Pujana, Lourdes Planelles, Eva González-Suárez
Publicado en: Cancer Research, Edición 76/19, 2016, Página(s) 5857-5869, ISSN 0008-5472
Editor: American Association for Cancer Research
DOI: 10.1158/0008-5472.can-15-2745

RANKL inhibitors for osteosarcoma treatment: hope and caution

Autores: Eva M. Trinidad, Eva González-Suárez
Publicado en: Annals of Translational Medicine, Edición 4/24, 2016, Página(s) 534-534, ISSN 2305-5839
Editor: Science Translational Medicine
DOI: 10.21037/atm.2016.12.10

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Autores: Roger von Moos, Luis Costa, Eva Gonzalez-Suarez, Evangelos Terpos, Daniela Niepel, Jean–Jacques Body
Publicado en: Cancer Treatment Reviews, 2019, ISSN 0305-7372
Editor: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.ctrv.2019.05.003

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Autores: Annette T. Byrne, Denis G. Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Andrew V. Biankin, Alejandra Bruna, Eva Budinská, Carlos Caldas, David K. Chang, Robert B. Clarke, Hans Clevers, George Coukos, Virginie Dangles-Marie, S. Gail Eckhardt, Eva Gonzalez-Suarez, Els Hermans, Manuel Hidalgo, Monika A. Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunh
Publicado en: Nature Reviews Cancer, Edición 17/4, 2017, Página(s) 254-268, ISSN 1474-175X
Editor: Nature Publishing Group
DOI: 10.1038/nrc.2016.140

European Network of Breast Development and Cancer turned 10 years: a growing family of mammary gland researchers

Autores: Zuzana Koledova, Beatrice A. Howard, Johanna Englund, Karsten Bach, Mohammed Bentires-Alj, Eva Gonzalez-Suarez
Publicado en: Breast Cancer Research, Edición 20/1, 2018, ISSN 1465-542X
Editor: Breast Cancer Research
DOI: 10.1186/s13058-018-1032-9

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

Autores: Adrián Sanz-Moreno, Sonia Palomeras, Kim Pedersen, Beatriz Morancho, Tomas Pascual, Patricia Galván, Sandra Benítez, Jorge Gomez-Miragaya, Marina Ciscar, Maria Jimenez, Sonia Pernas, Anna Petit, María Teresa Soler-Monsó, Gemma Viñas, Mansour Alsaleem, Emad A. Rakha, Andrew R. Green, Patricia G. Santamaria, Celine Mulder, Simone Lemeer, Joaquin Arribas, Aleix Prat, Teresa Puig, Eva Gonzalez-S
Publicado en: Breast Cancer Research, Edición 23/1, 2021, ISSN 1465-542X
Editor: Springer Nature
DOI: 10.1186/s13058-021-01390-2

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Autores: Clara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, Marina Ciscar, Alexandra Barranco, Enrique Hernández-Jiménez, Marion Maetens, Roberto Salgado, Maria Zafeiroglou, Pasquale Pellegrini, David Venet, Soizic Garaud, Eva M. Trinidad, Sandra Benítez, Peter Vuylsteke, Laura Polastro, Hans Wildiers, Philippe Simon, Geoffrey Lindeman, Denis Larsimont, Gert Van den Eynden, Chloé Velghe, Françoise R
Publicado en: Nature Communications, Edición 11/1, 2020, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-020-20138-8

Buscando datos de OpenAIRE...

Publicaciones

Compartir esta página

Descargar